Brief: Alkem Labs Launches Semaglutide Injection In India With Weekly Therapy Starting At 450 Rupees
21/03/2026 06:49
March 21 (Reuters) - Alkem Laboratories Ltd ALKE.NS: ALKEM LABS - LAUNCHES SEMAGLUTIDE INJECTION IN INDIA WITH WEEKLY THERAPY STARTING AT 450 RUPEES ALKEM LABS - SEMAGLUTIDE PRE-FILLED PEN AVAILABLE AT 1,800 RUPEES FOR FOUR DOSES PER MONTH ALKEM LABS - LAUNCHES SEMAGLUTIDE UNDER BRAND NAMES SEMASIZE, OBESEMA, AND HEPAGLIDE Source text: ID:nNSE7pZ5Bp Further company coverage: ALKE.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alkem Laboratories
See all newsBrief: Alkem Labs Approved Initiation Of Forensic Audit In Connection With Recent Incident Involving Alleged Misappropriation Of Funds By A Former Employee
Brief: Alkem Labs Launches Neuceno (Cenobamate) For Treatment Of Partial-Onset Seizures In Adult Patients
Brief: Alkem Labs Launches Renocia Exo, Ginsenoside Exosome-Based Hair Growth Serum
Brief: Alkem Labs Board Approves Investment Of Up To 750 Million Rupees For New Block At Baddi Manufacturing Facility
Brief: Alkem Laboratories Q1 Consol Revenue From Operations 37.4 Billion Rupees